Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|March 1, 1995
Low-dose cladribine for symptomatic hairy cell leukaemiaG Juliusson, R Lenkei, G Tjønnfjord, et al.
Therapeutic Drug Monitoring|July 1, 1990
Determination of plasma azathioprine and 6-mercaptopurine in patients with rheumatoid arthritis treated with oral azathioprineJ Liliemark, B Pettersson, P Lafolie, et al.
Medical Oncology (Northwood, London, England)|January 5, 2000
Distribution of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, fludarabine and cytarabine in mice: a whole-body autoradiography studyS Lindemalm, J Liliemark, B S Larsson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1995
Neutropenic fever following cladribine therapy for symptomatic hairy-cell leukemia: predictive factors and effects of granulocyte-macrophage colony-stimulating factorG Juliusson, R Lenkei, G Tjønnfjord, et al.
Leukemia & Lymphoma|July 27, 2016
Fine-Needle Aspiration Cytology and Immunocytochemistry of Abdominal Non-Hodgkin's LymphomasJ Liliemark, E Tani, B Christensson, et al.
Therapeutic Drug Monitoring|January 1, 1989
Pharmacokinetics of daunorubicin and doxorubicin in plasma and leukemic cells from patients with acute nonlymphoblastic leukemiaC Paul, J Liliemark, U Tidefelt, et al.
Therapeutic Drug Monitoring|August 1, 1994
Analysis of 2-chloro-2'-deoxyadenosine in human blood plasma and urine by high-performance liquid chromatography using solid-phase extractionF Albertioni, B Pettersson, V Reichelová, et al.
Cancer Letters|August 23, 1996
Ultrafiltration and subsequent high performance liquid chromatography for in vivo determinations of the protein binding of etoposideE Liliemark, L Herngren, B Pettersson, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Relationship between cladribine (CdA) plasma, intracellular CdA-5'-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL)F Albertioni, S Lindemalm, S Eriksson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Interspecies differences in the kinetic properties of deoxycytidine kinase elucidate the poor utility of a phase I pharmacologically directed dose-escalation concept for 2-chloro-2'-deoxyadenosineV Reichelová, G Juliusson, T Spasokoukotskaja, et al.
Pageof 8